Medium materiality6/10
Target upgraded, Moderna downgraded: Wall Street's top analyst calls
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
PNFP target raised to $118 from around $94.21; current price about $94.21; upside potential.
- Target above current price; upside potential.
Key facts
- 01
Target: $118
- 02
Posted price: $94.21
- 03
Analyst firm: Oppenheimer
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.